We are international
Donate
advocacy TEXT SIZE   
Public Policy Statements

Click below for IMF letters and statements aimed at federal decision makers on issues of concern to the myeloma community.

Health Care Reform
Access to Clinical Trials
Appropriations
Cancer Research, Early Detection, Prevention, and Treatment
08.31.10  IMF Comments to HHS, DOL, and IRS regarding Preexisting Condition Exclusions, Lifetime and Annual Limits, Rescissions, and Patient Protections in the Patient Protection and Affordable Care Act (August 2010)

08.18.10  CLC letter Urges Collaborative Action on Health Reform (February 2010)

08.18.10  Letter to HHS Urging the Elimination of Lifetime Caps for All Plans – New and Grandfathered – During Implementation of the Patient Protection and Affordable Care Act (PPACA) (May 2010)

02.03.10  Letter Supporting the Elimination of Lifetime and Annual Caps in the Final Health Reform Bill (January 2010)

01.22.10  NCCR Letter in Support of Maintaining the Clinical Trials Coverage Provision in the Final Health Reform Legislation (January 2010)

12.21.09  CLC Letter Endorsing Brown-Hutchison Amendment on Coverage of Clinical Trials in Health Care Reform

12.21.09  IMF Letter Endorsing Brown-Hutchison Amendment on Coverage of Clinical Trials in Health Care Reform

12.21.09  NCCR Letter Endorsing Brown-Hutchison Amendment on Coverage of Clinical Trials in Health Care Reform

10.19.09  Letter Supporting the Elimination of Preexisting Condition Exclusions and Waiting Periods for all Individuals in Health Care Reform (10/2009)

08.16.09  Sign on Letter Supporting Access to a Meaningful Health Benefits in Health Care Reform (06/2009)

08.04.09  Cancer Leadership Council (CLC) Comments on Key Elements of Health Care Reform (06/2009)

08.04.09  Cancer Leadership Council (CLC) Letter Urging COBRA Assistance in Stimulus Package (01/2009)